413 related articles for article (PubMed ID: 26920602)
1. Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.
Essebag V; Healey JS; Ayala-Paredes F; Kalfon E; Coutu B; Nery P; Verma A; Sapp J; Philippon F; Sandhu RK; Coyle D; Eikelboom J; Wells G; Birnie DH
Am Heart J; 2016 Mar; 173():102-7. PubMed ID: 26920602
[TBL] [Abstract][Full Text] [Related]
2. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).
Birnie DH; Healey JS; Wells GA; Ayala-Paredes F; Coutu B; Sumner GL; Becker G; Verma A; Philippon F; Kalfon E; Eikelboom J; Sandhu RK; Nery PB; Lellouche N; Connolly SJ; Sapp J; Essebag V
Eur Heart J; 2018 Nov; 39(44):3973-3979. PubMed ID: 30462279
[TBL] [Abstract][Full Text] [Related]
3. Pacemaker or defibrillator surgery without interruption of anticoagulation.
Birnie DH; Healey JS; Wells GA; Verma A; Tang AS; Krahn AD; Simpson CS; Ayala-Paredes F; Coutu B; Leiria TL; Essebag V;
N Engl J Med; 2013 May; 368(22):2084-93. PubMed ID: 23659733
[TBL] [Abstract][Full Text] [Related]
4. Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin.
Coleman CM; Khalaf S; Mould S; Wazni O; Kanj M; Saliba W; Cantillon D
Pacing Clin Electrophysiol; 2015 Jun; 38(6):731-7. PubMed ID: 25721150
[TBL] [Abstract][Full Text] [Related]
5. Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.
Essebag V; Healey JS; Joza J; Nery PB; Kalfon E; Leiria TLL; Verma A; Ayala-Paredes F; Coutu B; Sumner GL; Becker G; Philippon F; Eikelboom J; Sandhu RK; Sapp J; Leather R; Yung D; Thibault B; Simpson CS; Ahmad K; Toal S; Sturmer M; Kavanagh K; Crystal E; Wells GA; Krahn AD; Birnie DH
Circ Arrhythm Electrophysiol; 2019 Oct; 12(10):e007545. PubMed ID: 31610718
[TBL] [Abstract][Full Text] [Related]
6. Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: A single-center randomized prospective pilot trial.
Ricciardi D; Creta A; Colaiori I; Scordino D; Ragni L; Picarelli F; Calabrese V; Providência R; Ioannou A; Di Sciascio G
Pacing Clin Electrophysiol; 2018 Nov; 41(11):1476-1480. PubMed ID: 30132926
[TBL] [Abstract][Full Text] [Related]
7. Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study.
Essebag V; Verma A; Healey JS; Krahn AD; Kalfon E; Coutu B; Ayala-Paredes F; Tang AS; Sapp J; Sturmer M; Keren A; Wells GA; Birnie DH;
J Am Coll Cardiol; 2016 Mar; 67(11):1300-8. PubMed ID: 26988951
[TBL] [Abstract][Full Text] [Related]
8. Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations.
Kosiuk J; Koutalas E; Doering M; Sommer P; Rolf S; Breithardt OA; Nedios S; Dinov B; Hindricks G; Richter S; Bollmann A
Europace; 2014 Jul; 16(7):1028-32. PubMed ID: 24489073
[TBL] [Abstract][Full Text] [Related]
9. Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.
He H; Ke BB; Li Y; Han FS; Li X; Zeng YJ
J Interv Card Electrophysiol; 2017 Oct; 50(1):65-83. PubMed ID: 28842832
[TBL] [Abstract][Full Text] [Related]
10. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.
Schulman S; Healey JS; Douketis JD; Delaney J; Morillo CA
Thromb Res; 2014 Oct; 134(4):814-8. PubMed ID: 25127655
[TBL] [Abstract][Full Text] [Related]
11. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
[TBL] [Abstract][Full Text] [Related]
12. Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies.
Proietti R; Porto I; Levi M; Leo A; Russo V; Kalfon E; Biondi-Zoccai G; Roux JF; Birnie DH; Essebag V
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1461-79. PubMed ID: 25967723
[TBL] [Abstract][Full Text] [Related]
13. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
[TBL] [Abstract][Full Text] [Related]
14. Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey.
Nascimento T; Birnie DH; Healey JS; Verma A; Joza J; Bernier ML; Essebag V
Can J Cardiol; 2014 Feb; 30(2):231-6. PubMed ID: 24461924
[TBL] [Abstract][Full Text] [Related]
15. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
Du L; Zhang Y; Wang W; Hou Y
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
[TBL] [Abstract][Full Text] [Related]
16. Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.
Essebag V; AlTurki A; Proietti R; Healey JS; Wells GA; Verma A; Krahn AD; Simpson CS; Ayala-Paredes F; Coutu B; Leather R; Ahmad K; Toal S; Sapp J; Sturmer M; Kavanagh K; Crystal E; Leiria TLL; Seifer C; Rinne C; Birnie D;
Int J Cardiol; 2019 Aug; 288():87-93. PubMed ID: 31056413
[TBL] [Abstract][Full Text] [Related]
17. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.
Cheng A; Nazarian S; Brinker JA; Tompkins C; Spragg DD; Leng CT; Halperin H; Tandri H; Sinha SK; Marine JE; Calkins H; Tomaselli GF; Berger RD; Henrikson CA
Heart Rhythm; 2011 Apr; 8(4):536-40. PubMed ID: 21147261
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study.
Sant'anna RT; Leiria TL; Nascimento T; Sant'anna JR; Kalil RA; Lima GG; Verma A; Healey JS; Birnie DH; Essebag V
Pacing Clin Electrophysiol; 2015 Apr; 38(4):417-23. PubMed ID: 25546244
[TBL] [Abstract][Full Text] [Related]
20. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
